Crab blood to remain big pharma's standard as industry group rejects substitute

Animal rights groups have been pushing a synthetic alternative to horseshoe crab blood in drug safety testing

Horseshoe crabs’ icy-blue blood will remain the drug industry’s standard for safety tests after a powerful US group ditched a plan to give equal status to a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups.

The crabs’ copper-rich blood clots in the presence of bacterial endotoxins and has long been used in tests to detect contamination in shots and infusions.

Continue reading...

from The Guardian https://ift.tt/2Mkg8uF

Comments

Popular posts from this blog

Ply in the sky: the new materials to take us beyond concrete | Fiona Harvey

Forgotten plays: No 5 – Owners (1972) by Caryl Churchill

The 20 best songs of 2020